Nigeria Targets 11 New Pharmaceutical Manufacturing Projects To Boost Local Drug Production

LAGOS, NIGERIA — Nigeria’s federal government has announced ambitious plans to commission at least 11 pharmaceutical manufacturing projects in 2026, marking a major expansion in local drug production capacity and establishing the nation as West Africa’s primary health technology and supply hub.
The National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain stated that “the projects, which are already underway, reflect growing investor confidence in Nigeria’s pharmaceutical sector”. Nigeria targets 11 new pharmaceutical manufacturing projects across strategic healthcare sectors to satisfy domestic requirements and scale regional exports.
Facility Allocation and Regional Trade Potential
The upcoming manufacturing hubs target critical clinical gaps while expanding commercial outreach across the continent:
| Strategic Region / State | Specialized Focus | Commercial Target |
| Ogun & Nasarawa States | Diagnostic Test Kit Production | Local clinical shortages & regional exports |
| Anambra State | Bayer Technology Transfer (Family Planning) | Domestic market & West Africa |
| West African Sub-Region | Regional Export Market Expansion | 460 million consumers |
How Nigeria Drives Local Drug Production Expansion
By expanding local drug production, Nigeria aims to curb import dependence and lower long-term healthcare costs. Facilities will create employment for pharmaceutical scientists, technicians, and support staff, while training programs under the IMPACT Project continue to upskill over 100 young professionals in process standardization and regulatory compliance.
Investor interest remains high: four pharmaceutical firms ranked among the Nigerian Exchange’s top 10 best-performing companies in 2025. In parallel, Nigeria’s accession to the African Medicines Agency streamlines cross-border regulatory approvals, easing entry into broader African Union markets. Coupled with targeted industrial incentives and infrastructure upgrades, these 11 projects aim to secure continental health sovereignty through sustainable local drug production.
Why It Matters: Building West African pharmaceutical manufacturing capacity reduces medicine import dependence, secures health supply chains, and fosters domestic industrial expertise.
Source: Premium Times Nigeria, September 2026,



